| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731573 | 6480464 | Ethinyl Estradiol results in increased expression of PPM1A mRNA | CTD | PMID:17942748 PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731573 | 6480464 | Ethinyl Estradiol results in increased expression of PPM1A mRNA | CTD | PMID:17555576 PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:731573 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPM1A mRNA | CTD | PMID:17942748 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:731573 | 6480464 | Dihydrotestosterone results in decreased expression of PPM1A mRNA | CTD | PMID:17023530 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731573 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPM1A mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731573 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPM1A mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731573 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPM1A mRNA | CTD | PMID:19770486 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:731573 | 6480464 | Glucosamine results in decreased expression of PPM1A mRNA | CTD | PMID:17178593 |
| 2-methylcholine | affects expression | ISO | RGD:731572 | 6480464 | beta-methylcholine affects the expression of PPM1A mRNA | CTD | PMID:21179406 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:731573 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PPM1A mRNA | CTD | PMID:19285098 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PPM1A mRNA | CTD | PMID:19162173 |
| aflatoxin B1 | decreases expression | ISO | RGD:731573 | 6480464 | Aflatoxin B1 results in decreased expression of PPM1A mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:731573 | 6480464 | Glucosamine results in decreased expression of PPM1A mRNA | CTD | PMID:17178593 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PPM1A mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731572 | 6480464 | Benzo(a)pyrene results in decreased expression of PPM1A mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731573 | 6480464 | Benzo(a)pyrene results in decreased expression of PPM1A mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731573 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PPM1A mRNA] | CTD | PMID:22228805 |
| beta-D-glucosamine | decreases expression | ISO | RGD:731573 | 6480464 | Glucosamine results in decreased expression of PPM1A mRNA | CTD | PMID:17178593 |
| cadmium dichloride | increases expression | ISO | RGD:731572 | 6480464 | Cadmium Chloride results in increased expression of PPM1A mRNA | CTD | PMID:12160620 |
| choline | multiple interactions | ISO | RGD:731573 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPM1A gene | CTD | PMID:20938992 |
| cisplatin | decreases response to substance | ISO | RGD:731572 | 6480464 | PPM1A results in decreased susceptibility to Cisplatin | CTD | PMID:21849418 |
| cisplatin | multiple interactions | ISO | RGD:731572 | 6480464 | [PPM1A results in decreased phosphorylation of BAD protein] which results in increased susceptibility to Cisplatin | CTD | PMID:21849418 |
| clofibrate | decreases expression | ISO | RGD:731573 | 6480464 | Clofibrate results in decreased expression of PPM1A mRNA | CTD | PMID:17585979 |
| clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of PPM1A mRNA | CTD | PMID:15860345 |
| coumestrol | decreases expression | ISO | RGD:731572 | 6480464 | Coumestrol results in decreased expression of PPM1A mRNA | CTD | PMID:19167446 |
| diarsenic trioxide | decreases expression | ISO | RGD:731572 | 6480464 | arsenic trioxide results in decreased expression of PPM1A mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of PPM1A mRNA | CTD | PMID:21266533 |
| dioxygen | increases expression | ISO | RGD:731573 | 6480464 | Oxygen deficiency results in increased expression of PPM1A mRNA | CTD | PMID:22629407 |
| dioxygen | multiple interactions | ISO | RGD:731573 | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PPM1A mRNA] | CTD | PMID:22629407 |
| doxorubicin | decreases expression | ISO | RGD:731573 | 6480464 | Doxorubicin results in decreased expression of PPM1A mRNA | CTD | PMID:21040762 |
| doxorubicin | multiple interactions | ISO | RGD:731573 | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of PPM1A mRNA | CTD | PMID:21040762 |
| folic acid | multiple interactions | ISO | RGD:731573 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPM1A gene | CTD | PMID:20938992 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of PPM1A mRNA | CTD | PMID:15860345 |
| L-methionine | multiple interactions | ISO | RGD:731573 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPM1A gene | CTD | PMID:20938992 |
| paracetamol | affects expression | ISO | RGD:731573 | 6480464 | Acetaminophen affects the expression of PPM1A mRNA | CTD | PMID:17562736 |
| pirinixic acid | increases expression | ISO | RGD:731573 | 6480464 | pirinixic acid results in increased expression of PPM1A mRNA | CTD | PMID:18301758 PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:731573 | 6480464 | pirinixic acid results in increased expression of PPM1A mRNA | CTD | PMID:17426115 PMID:18301758 |
| propiconazole | decreases expression | ISO | RGD:731573 | 6480464 | propiconazole results in decreased expression of PPM1A mRNA | CTD | PMID:21278054 |
| tamoxifen | affects expression | ISO | RGD:731573 | 6480464 | Tamoxifen affects the expression of PPM1A mRNA | CTD | PMID:17555576 |
| testosterone enanthate | affects expression | ISO | RGD:731572 | 6480464 | testosterone enanthate affects the expression of PPM1A mRNA | CTD | PMID:17440010 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of PPM1A mRNA | CTD | PMID:19448997 |
| trichloroethene | multiple interactions | ISO | RGD:731573 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of PPM1A mRNA] | CTD | PMID:15363585 |
| valproic acid | increases expression | ISO | RGD:731572 | 6480464 | Valproic Acid results in increased expression of PPM1A mRNA | CTD | PMID:19101580 |
| zinc atom | increases expression | ISO | RGD:731572 | 6480464 | Zinc deficiency results in increased expression of PPM1A mRNA | CTD | PMID:18356318 |
| zinc(0) | increases expression | ISO | RGD:731572 | 6480464 | Zinc deficiency results in increased expression of PPM1A mRNA | CTD | PMID:18356318 |